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 Introduction 
 Morphological abnormalities of blood capillaries and 
lymphatic capillaries are described in psoriasis. It is sug-
gested that they play a fundamental role in the develop-
ment of psoriatic plaques  [1–3] . 
 Histological and immunohistological as well as elec-
tron microscopic studies revealed tortuous and expanded 
skin capillaries with an increased lymphatic vessel den-
sity in psoriatic plaques  [1, 4, 5] . Following the treatment 
of psoriasis a reduced number of lymphatic capillaries of 
the skin were reported  [3] . Previous electron microscop-
ic studies and skin biopsies of plaques demonstrated nu-
merous abnormal dilated lymphatic capillaries within the 
lesions and less prominent ones in the uninvolved skin of 
psoriatic patients  [5, 6] . Furthermore, an increased num-
ber, width and length of the blood microvessels were 
found in skin biopsies of the plaques  [7] .
 Currently, it is not clear whether there is only an ana-
tomic abnormality of microvessels in psoriatic plaques or 
whether this also translates into a functional alteration 
with impaired drainage of lymphatic fluid and reduced 
perfusion. 
 To our knowledge, there are only three studies inves-
tigating the lymphatic drainage in psoriatic skin. All show 
an increased drainage  [3, 8, 9] .
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 Abstract 
 Introduction: Morphological abnormalities of microvessels 
are described in psoriasis. However, there are conflicting 
data as to whether their function is also altered.  Objective: 
Our aim was to study the morphology and function of the 
lymphatic capillaries of psoriatic skin.  Methods: Morphology 
and permeability of initial lymphatics were studied by micro-
lymphography and densitometry in 20 patients. Perfusion 
was studied by laser Doppler fluxmetry.  Results: Permeabil-
ity of lymphatics in plaques was increased by 7.6% com-
pared to unafflicted skin (p < 0.001). Lymphatic vessel den-
sity and the extension of dye in lymphatic networks were 
not significantly different between involved and uninvolved 
areas. Both sites showed a wide range of diameters of lym-
phatics. The median laser Doppler flux in plaques was in-
creased by 144% (91–380%) compared to unaffected skin
(p < 0.001).  Conclusions: Increased permeability of lymphat-
ics and increased blood flow was demonstrated in vivo in 
psoriatic skin lesions. These findings may reflect the local in-
flammatory process and may be used as markers when 
studying new therapeutic approaches for psoriasis. 
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 Laser Doppler fluxmetry with laser Doppler perfusion 
imaging (LDPI) or monitoring is a noninvasive technique 
to demonstrate skin perfusion. In several studies an in-
creased laser Doppler flux in the plaques has been dem-
onstrated  [10–12] . 
 Although the exact pathogenetic mechanisms leading 
to the microvascular abnormalities in psoriasis are un-
known, there are indications that vascular endothelial 
growth factor-A (VEGF-A) plays a central role. It could 
be shown that transgenic mice that overexpress VEGF-A 
in the epidermis underwent a lymphatic vessel prolifera-
tion and enlargement and an increased and prolonged 
inflammatory response with skin changes resembling hu-
man psoriasis  [6] . Systemic inhibition of VEGF-A or its 
receptors reduced the skin inflammation and also de-
creased lymphatic vessel size in different mouse models 
of psoriasis  [13, 14] . Interestingly, there is increasing evi-
dence that blocking lymphangiogenesis prolongs the 
course of inflammation, as seen in mouse models of 
chronic airway inflammation  [15] , chronic rheumatoid 
arthritis  [16] and chronic skin inflammation  [14] . In con-
trast, stimulation of lymphangiogenesis and lymphatic 
function reduced chronic skin inflammation and chronic 
rheumatoid arthritis  [14, 17] .
 Thus, inhibition of VEGF-A bioactivity and stimula-
tion of lymphatic function might be a new therapeutic 
approach for psoriasis.  Therefore, the aim of this study 
was to further characterize the function and morphology 
of lymphatic vessels in psoriatic plaques.
 Patients and Methods 
 Patients 
 In this prospective study, outpatients suffering from moderate 
psoriasis vulgaris (plaque-type psoriasis) were included from June 
2010 to April 2011. All patients had active psoriatic plaques and 
were treated either with phototherapy and topical agents or with 
systemic therapy. 
 In all patients the morphology and function of the lymphatic 
capillaries in the psoriatic plaques were studied by fluorescence 
microlymphography; the blood perfusion of the psoriatic skin le-
sion was examined by LDPI.
 The study was approved by the local ethical committee (EK-
StV-Nr 2010/00144/5) and all patients gave written informed con-
sent.
 Fluorescence Microlymphography 
 The technique of fluorescence microlymphography has been 
described in detail  [18] . Using a steel microcannula with a tip di-
ameter of 0.2 mm (Arnold Bott, Zurich, Switzerland) connected 
to a microsyringe (Hamilton, Bonaduz, Switzerland), 10 μl of a 
sterilized 25% solution of FITC-(fluorescein isothiocyanate) dex-
tran 150,000 MW (TdB Consultancy AB, Uppsala, Sweden) was 
injected into the subepidermal layer of the skin in the middle of 
the psoriatic plaques. In large plaques a second injection at the 
border was performed to visualize lymphatics crossing from 
healthy into diseased skin. As large molecules are exclusively 
drained by the lymphatic system, the fluorescent dextran mole-
cules move into the initial lymphatics and can be visualized by a 
fluorescence video microscopy system. This consists of an inci-
dent light fluorescence microscope (Leica, Heerbrugg, Switzer-
land), a 3-charge-coupled device video camera (model DXC-
930P, Sony, Tokyo, Japan) with a camera adapter and sensitivity 
on automatic control (CMA-D2, Sony), a timer (VTG-22) and 
scale marker (IV-600; both from For-A-Company, Tokyo, Japan), 
a monitor (Picture Monitor model PM171T, Ikegami Tsushinki, 
Tokyo, Japan) and a personal computer with a recorder software 
(synedra View and Image View software; synedra Information 
Technologies, Innsbruck, Austria). The microscope was equipped 
with 1.0/0.04, 2.5/0.08, 6.3/0.20 and 10/0.25 planar objectives 
(Leica), which allow a magnification of ×24, ×62, ×165 and ×240, 
respectively, on the monitor. The fluorescence excitation filter 
works at 450–490 nm and the barrier filter at 515 nm. 
 Morphology of Lymphatic Vessels 
 The following parameters have been evaluated offline from 
the recordings 10 min after dye injection: presence and density 
of visualized lymphatic meshes, fragmentation of the superficial 
lymphatic network (defined as network with interruptions of the 
meshes), cutaneous backflow (defined as abnormal retrograde 
flow from deep to cutaneous lymphatics away from the main net-
work), and maximal extension of the fluorescent macromole-
cules into the lymphatic network in the lateral, proximal, medial 
and distal direction as a measure for lymphatic drainage capacity 
into deeper channels and diameter of single lymphatic microves-
sels. 
 Lymphatic Vessel Density 
 Because it is difficult to count the number of vessels in a net-
work, we used the total length of the lymphatic capillaries in a 
square millimeter as an equivalent to the lymphatic vessel density. 
The measurements were taken offline from the recordings 10 min 
after dye injection. The mean value of three measurements per re-
cording was calculated. The 1-mm 2 large region of interest was 
localized about 2 mm away from the dye depot and where the lym-
phatic network was delineated.
 Lymphatic Permeability  
 The lymphatic wall is permeable to water and small solutes but 
less to larger molecules such as FITC-dextran 150,000 MW in 
healthy skin. High peaks of fluorescent light intensity remain lo-
cated over the capillary. Increased permeability is characterized by 
increased interstitial fluorescence intensity and a lower peak of 
light intensity over the vessel  [19] . The permeability of initial lym-
phatics was determined by video densitometry. The recordings of 
the lymphatic network obtained during the microlymphography 
10 min after dye injection were digitized and colors were trans-
formed into black and white (synedra View 3 and Image View 
software; synedra Information Technologies). Single images of 
well-delineated lymphatic capillaries as far away as possible from 
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the dye depot were chosen. A 10 × 10 pixel region of interest was 
localized over the brightest point in the lymphatic capillary and 
0.5 mm away from the capillary wall in the interstitial tissue. The 
light intensity was measured 3 times by the image processing and 
analysis software ImageJ (a free available Java-based public-do-
main image processing and analysis program developed at the Na-
tional Institutes of Health by Wayne Rasband of the National In-
stitute of Mental Health) and the median value was calculated. 
Light intensity was expressed in arbitrary density units and the 
light intensity in the vessel defined as 100%. Permeability of cuta-
neous lymphatic vessels was calculated as follows: (light intensity 
in the vessel)/100% × (light intensity in the interstitium).
 Laser Doppler Perfusion Imaging 
 LDPI is a more recent method to determine the local distribu-
tion of flux over a skin area without direct contact with the tissue 
surface. The laser light was emitted from the source placed ap-
proximately 20 cm above the skin  [20, 21] . Flux is a relative mea-
sure of the microvascular flow, represents the product of speed and 
number of cells and is expressed in arbitrary perfusion units. The 
LDPI provides color-coded 2D images of the blood flow through 
the investigated tissue. In the pictures the lowest perfusion is rep-
resented by a dark blue color; when perfusion increases the colors 
change from light blue, green, yellow and orange to red. These im-
ages were analyzed with the LDPIWin system software (Perimed 
AB, Stockholm, Sweden). The same region of interest in the sub-
sequent two LDPI images of a certain skin area was selected and 
the median flux was calculated. The flux of the normal skin was 
defined as 100%. The region of interest was the whole area of a 
psoriatic plaque.
 The LDPI has an average measurement depth in human skin 
of about 1–1.5 mm and therefore the nutritive and thermoregula-
tive microcirculation is examined  [21, 22] . In this study a PIM 2.0 
laser Doppler perfusion imager (PeriScan PIM II, Perimed AB) 
was used, with a low-power helium-neon laser beam (1 mW, 
670 nm). 
 Investigational Protocol 
 All measurements were performed in a psoriatic plaque at one 
of the extremities or at the upper body when no plaque was present 
at the extremity. The same measurements were performed in the 
unaffected skin close to the plaque. During the procedure patients 
were in supine position with the leg at heart level. The temperature 
of the air-conditioned examination room was maintained between 
22 and 26  °  C as recommended  [23] .
 Statistical Analysis 
 Statistical analysis was performed using the statistical program 
IBM SPSS Statistics 20 (SPSS Inc., Chicago, Ill., USA). Results are 
presented as median and range. p values for nonnormal distrib-
uted results were calculated by Wilcoxon signed ranks test and for 
normal distributed results by the paired samples t test. Interplaque 
and intercapillary reliabilities were calculated as intraclass correla-
tions (ICC) using restricted maximum likelihood estimators of 
variance components in a one-way model.
 Results 
 Patients 
 Twenty psoriatic lesions of 20 patients with psoriasis 
vulgaris (4 female, median age 50 years, range 29–79) 
were studied. The mean duration of the disease was 16 
years (range 1–55). The patients were examined when the 
psoriasis was in an active but stable phase; 1 patient had 
no treatment because the psoriasis had been recently di-
agnosed, 11 patients received a systemic treatment (meth-
otrexate n = 6, biologics n = 4, PUVA n = 1, narrow band 
UVB n = 2) and 14 patients received a topical treatment 
( table 1 ).
 Fluorescence Microlymphography 
 In 3 patients the assessment of the skin lymphatics was 
not possible due to impaired visibility of lymphatic vessels. 
 Diameters of 2–10 capillaries were measured per pa-
tient and lymphatic network. Because of the large variabil-
ity of diameters (ICC 0.52 within plaques and 0.36 in un-
involved skin), medians of corresponding measures were 
analyzed. These diameters were significantly smaller in 
the plaques (median 44 μm, range 31–85) than in the un-
afflicted skin (median 62 μm, range 47–110, p = 0.001) 
( fig. 1 ,  2 ). Extensions of two plaques were measured per 
patient. They had a high reliability (ICC 0.75 of single 
measures) and hence the mean of these two measures was 
analyzed. No reliability for extensions in unaffected skin 
could be calculated. The median extension of the dye was 
equal between plaques (3.0 mm, range 1–12) and perile-
sional skin (2.5 mm, range 1–16, p = 0.357) ( fig. 3 ). Impor-
tantly, the permeability of the lymphatics in the plaques 
was significantly increased by 7.6% (95% confidence inter-
val, CI, 10.4–4.8) from 73.2% (range 64.7–89.7) in the un-
involved skin to 81.6% (range 70.2–92.8) in the plaque
(p < 0.001) ( fig. 4 ). The density of the depicted lymphatic 
vessels, expressed as the total length of the lymphatic net-
work in a square millimeter, was very variable and not 
significantly increased in the plaques. One to three lym-
phatic networks per patient were measured. The mean val-
ue in the plaques was 2,773 μm (range 1,033–6,931) and in 
the uninvolved skin 2,162 μm (range 659–6,180, p = 0.084) 
( fig. 5 ). Neither fragmentation of the superficial lymphat-
ic network nor cutaneous backflow were observed.
 Laser Doppler Perfusion Imaging 
 The flux of one plaque per patient was measured. The 
median laser Doppler flux in plaques was significantly in-
creased to 144% (range 91–380) of the flux in the unin-
volved skin (p < 0.001) ( fig. 6 ).
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 Discussion 
 The two main findings of this study were that the lym-
phatic capillaries in psoriatic skin are very variable in size 
and density, even more in the perilesional skin than with-
in the psoriatic lesions itself, and that their permeability 
is increased in the plaque. 
 The diameter of the lymphatics was significantly 
smaller in the plaques (with a median diameter of 44 μm) 
compared to the perilesional skin (with a median diam-
a b
 Fig. 1. Fluorescence microlymphography in the skin of a patient with psoriasis shows the network of smaller lymphatics in the plaque 
( a ) than in the perilesional skin ( b ). Magnification ×24. 
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 Fig. 2. The median diameter of lymphatic 
capillaries in the plaques is significantly 
smaller than in the perilesional skin. The 
number of measurements in plaque was 
111 and in uninvolved skin it was 99. 
*** p = 0.001. 
 Fig. 3. The median extension of dye in lym-
phatic networks of plaques and perilesion-
al skin was not significantly different. The 
number of measurements in plaque was 38 
and in uninvolved skin it was 22. n.s. = Not 
significant. 
 Fig. 4. The permeability of the lymphatics 
in the psoriatic plaques was significantly 
increased. The number of measurements in 
plaque was 40 and in uninvolved skin it was 
40. *** p < 0.001. 
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eter of 62 μm that corresponds to the diameter of normal 
nonpsoriatic skin)  [24] . These small lymphatic capillaries 
seem to be proliferating vessels probably in response to 
the treatment of the inflammatory process. Our in vivo 
findings are in contrast to previous micromorphological 
results of electron microscopic and immunohistological 
investigations demonstrating numerous dilated lymphat-
ic capillaries in the skin of psoriatic patients  [5, 6] . In most 
of these studies the treatment was interrupted prior to the 
examination. The electron microscopic studies by Braver-
man and Yen  [5] in the psoriatic skin also showed the 
presence of isolated blind lymphatic channels between 
the interconnecting lymphatic capillaries. The authors 
hypothesized that these channels might represent a lym-
phatic reserve left by previous inflammatory episodes 
that is capable of proliferating and connecting with the 
existing channels in response to inflammation or edema 
 [5] . The classification of lymphatic skin vessels by diam-
eter (<10, 10–17, 18–24 and >24 μm) proposed by Jac-
kowski et al.  [25] to show the distribution of the micro-
vessel calibers during different stages after radiotherapy 
of tumors was not applicable to our in vivo results in pso-
riatic patients since these lymphatics were larger than 
24 μm.
 In the present study no significant difference of the 
lymphatic vessel density between the psoriatic lesions and 
the uninvolved skin was found. Cliff et al.  [26] published 
microlymphographic results in 6 patients with an even 
lesser density in the psoriatic lesion than in the nonle-
sional skin. Obviously, the microlymphographic findings 
are at odds with the higher density in the plaques de-
scribed in previous ultrastructural studies with electron 
microscopy, histological and immunohistochemical ex-
aminations. Histological studies report an increase of the 
lymphatic vessel density or a shift of lymphatic vessels 
from the upper dermal plexus in deeper parts of the der-
mis  [1] . In their immunohistochemical studies Fiedler et 
al.  [4] found a marked increase in D2-40-positive lym-
phatic vessel density above the upper blood plexus in pso-
riatic plaques compared to normal skin samples. Lym-
phatic vessel segments in the dermal papillae were found 
in psoriasis in 87.5% and in normal skin in 9.4% of the 32 
samples. The authors explain the higher lymphatic den-
sity by a possible upregulation to meet the needs of a bet-
ter lymphatic drainage of the increased interstitial fluid in 
the plaques. This could well explain that following the 
treatment of psoriasis the number of lymphatic capillaries 
is reduced corresponding to the reduced inflammation 
 [3] . It is also known that the lymphatic capillaries vanish 
when the psoriatic plaque starts to resolve  [27] . This may 
explain the lower density in our treated patients.
 Furthermore, in our study the extension of dye in the 
superficial lymphatic network of the psoriatic skin was 
normal with median values less than 12 mm, indicating a 
normal lymphatic drainage both in the lesional and the 
perilesional skin  [18] . This normal lymphatic drainage in 
the plaques was also described by Cliff et al.  [26] . It is 
known from the examination by Staberg et al. [8, 9] that 
the lymphatic albumin clearance is increased in psoriatic 
skin when compared with normal skin. The authors ex-
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 Fig. 5. The lymphatic vessel density in pso-
riatic plaques was not significantly in-
creased. The number of measurements in 
plaque was 54 and in uninvolved skin it was 
54. n.s. = Not significant. 
 Fig. 6. The median flux in the psoriatic skin 
was significantly higher than in the perile-
sional skin (p < 0.001). The number of 
measurements in plaque and in uninvolved 
skin was 20. PU = Perfusion units. 
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plain the presence of edema in the plaque with an in-
creased leakage of the blood capillaries. The increased 
lymphatic drainage might compensate the fluid accumu-
lation. 
 The significantly increased permeability of the lym-
phatics by 7.5% indicates not only morphological but also 
functional changes of the lymphatics in psoriatic plaques. 
To our knowledge this is the first time that measurements 
of permeability of lymphatics in psoriatic skin has be-
come published. Adequately measured lymphatic perme-
ability is shown since it is not confounded by edema. On 
the other hand the size of the measured area was limited 
by the vessel diameter. Therefore, a 10 × 10 pixel region 
was chosen for the calculation of the permeability. The 
number of measurement points was limited by the inter-
fering light intensity of neighboring vessels. The inter- 
and intraindividual representativeness could not be dem-
onstrated. 
 The discrepancy between our results and the results 
published to date might be due to the different inflamma-
tory state of the studied plaques. Moreover, the results 
vary widely with the method of detection. In the present 
in vivo study perfused microvessels and their function are 
presented. In all previous studies except one micromor-
phological findings of (immune) histology or electron 
microscopy are described. These methods also show the 
nonperfused microvessels and there is a tissue-shrinking 
artifact by fixation; both might influence the results.
 Further studies using in vivo microlymphography of 
the psoriatic plaques at different time points with differ-
ent therapeutic regiments will be performed to confirm 
this hypothesis. The results of these studies will be more 
reliable if they are conducted with patients having an ac-
tive disease before therapy and then compared with pa-
tients after successful therapy or at least during therapy.
 In the present study the arterial perfusion measured by 
laser Doppler flux was increased in the plaques compared 
to the perilesional skin. The higher flux within the psori-
atic lesions was also mentioned in other studies  [12] . It is 
also known that the locally and neutrally mediated vaso-
regulation is intact in psoriatic plaques  [28–30] . Davison et 
al.  [7] demonstrated that the flux is increased up to 4 mm 
away from the plaque, whereas no epidermal changes and 
no lymphocytic excess have been confirmed histologically 
at the comparable active edge. This may indicate that an 
increased blood flow occurs early in psoriatic lesions well 
before the histological changes are present. The underlying 
mechanism of the increased blood flow in the psoriatic 
plaques is not known. Psoriasis is an autoimmune disease 
with inflammation in the active plaques. The elevated 
blood flow might be an indicator of the cutaneous inflam-
mation and vascularization in the plaques as well as an in-
dicator of the expansion of the plaques  [7, 31] . 
 Therefore, laser Doppler fluxmetry might be a marker 
for monitoring the effect of treatment of psoriasis. There 
are some studies examining this topic but the results are 
not uniform: PUVA phototherapy may have an influence 
on the dermal microvascular blood flow in contrast to 
narrow-band UVB phototherapy and pulsed dye laser 
 [10, 11, 30, 32] . Alternatively, laser Doppler flux may not 
be a good surrogate marker of clinical response to nar-
row-band UVB or laser phototherapy in contrast to 
PUVA phototherapy.
 Conclusion 
 In psoriatic skin lesions increased permeability of lym-
phatics and increased arterial skin perfusion are present. 
These in vivo findings may reflect the local inflammatory 
process. Both lymphatic permeability and laser Doppler 
flux might be good markers when studying new therapeu-
tic options for psoriasis. 
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